European Biotech Acquisition Corp.
European Biotech Acquisition Corp. (EBAC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EBAC · as of Jun 9, 2026
Key Statistics
Explore European Biotech Acquisition Corp. Data
ebac stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
ebac competitorsEBAC
APCA
BTWN
CONX
GSQB
PRBMStock Performance
Full HistoryAbout European Biotech Acquisition Corp.
European Biotech Acquisition Corp. (EBAC) is presently not engaged in substantial business operations. Instead, its core purpose is to facilitate a business combination, potentially through a merger, …
what is european biotech acquisition corp. · ebac stock overview · european biotech acquisition corp. company profile · who is european biotech acquisition corp. ceo · ebac NASDAQ · european biotech acquisition corp. headquarters · european biotech acquisition corp. business segments
About Stock Overview & Key Data
European Biotech Acquisition Corp. (EBAC) is a Financial Services company in the Shell Companies industry, listed on NASDAQ since May 11, 2021. As of the latest trading session, EBAC stock price is $11.19, with a market capitalization of $183.5M. The stock has returned +14.89% over the past 12 months and +10.79% year-to-date.
In fiscal year 2022, European Biotech Acquisition Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, European Biotech Acquisition Corp. (EBAC) stock price is $11.19. The stock is traded on NASDAQ under the ticker symbol EBAC. The 52-week range is $9.28 – $14.10.